evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
Published 5 months ago • 92 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
3:09
destiny-breast02: high levels of efficacy of t-dxd in previously treated her2 breast cancer
-
4:15
debbrah: t-dxd in her2 or her2-low advanced breast cancer with cns involvement
-
0:56
the future of cancer treatment: multimodal therapies
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
2:30
destiny-breast04: t-dxd in her2-low breast cancer regardless of molecular markers
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
1:05
dr lin on the efficacy of t-dxd in her2 advanced breast cancer with cns metastases
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
4:07
safety follow-up of the randomized, phase 3 study destiny-breast03